NCT06851988 Can Exercise Ameliorate Immunosenescence and Thereby Reduce Relapse in Head and Neck Cancer Patients
| NCT ID | NCT06851988 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chang Gung Memorial Hospital |
| Condition | Aging |
| Study Type | INTERVENTIONAL |
| Enrollment | 180 participants |
| Start Date | 2023-05-03 |
| Primary Completion | 2025-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 180 participants in total. It began in 2023-05-03 with a primary completion date of 2025-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Through the implementation of this three-year project, investigators expect to find a safe and effective exercise prescription for patients with oral cancer after surgery. The findings will encourage and promise and add further support to the concept that exercise prescription is worth implementation as part of care for the patients with head and neck cancer.
Eligibility Criteria
Inclusion Criteria: 1. Age ≥20 2. Pathology:Squamous cell carcinoma 3. Need CCRT treatment 4. ECOG PS\<2 5. Agree with blood drawing, excise training, questionnaire Exclusion Criteria: 1. ECOG PS≥2 2. Unable to tolerate basic exercise, or CCRT treatment 3. Mental illness or any medical illness or concurrent illness that may be aggravated by exercise training or unmanageable 4. Any medical condition that unsuitable for exercise 5. Disagree to trial procedures: exercise, blood draws, questionnaire
Contact & Investigator
Chia-Hsun Hsieh
STUDY CHAIR
New Tipei City Tucheng Hospital
Frequently Asked Questions
Who can join the NCT06851988 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 80 Years, studying Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06851988 currently recruiting?
Yes, NCT06851988 is actively recruiting participants. Contact the research team at troublefup6@cgmh.org.tw for enrollment information.
Where is the NCT06851988 trial being conducted?
This trial is being conducted at New Taipei City, Taiwan.
Who is sponsoring the NCT06851988 clinical trial?
NCT06851988 is sponsored by Chang Gung Memorial Hospital. The principal investigator is Chia-Hsun Hsieh at New Tipei City Tucheng Hospital. The trial plans to enroll 180 participants.